UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The Proceedings of the Initial Meeting of the Society of Hematologic Oncology 2013

Clinical lymphoma, myeloma and leukemia, 2014-09, Vol.14, p.S1-S1

2014

Volltextzugriff (PDF)

Retrospect of Hematological Malignancies 2012

Clinical lymphoma, myeloma and leukemia, 2013-09, Vol.13, p.S271-S271

2013

Volltextzugriff (PDF)

The Combination of Alemtuzumab [Continuous Intravenous Infusion (civ) Followed by Subcutaneous Injection (sc)] Plus Rituximab Has Activity in Patients (pts) with Relapsed Chronic Lymphocytic Leukemia (CLL)

Blood, 2006-11, Vol.108 (11), p.2827-2827

2006

Volltextzugriff (PDF)

Bronchial thermoplasty: Long-term safety and effectiveness in patients with severe persistent asthma

Journal of allergy and clinical immunology, 2013-12, Vol.132 (6), p.1295-1302.e3

2013

Volltextzugriff (PDF)

Pregnancy Among Patients With Chronic Myeloid Leukemia Treated With Imatinib

Journal of clinical oncology, 2006-03, Vol.24 (7), p.1204-1208

2006

Volltextzugriff (PDF)

Complete cytogenetic and molecular responses to interferon‐α‐based therapy for chronic myelogenous leukemia are associated with excellent long‐term prognosis

Cancer, 2003-02, Vol.97 (4), p.1033-1041

2003

Volltextzugriff (PDF)

Results of decitabine (5‐aza‐2′deoxycytidine) therapy in 130 patients with chronic myelogenous leukemia

Cancer, 2003-08, Vol.98 (3), p.522-528

2003

Volltextzugriff (PDF)

Pharmacokinetics and Pharmacodynamics of Plasma Clofarabine and Cellular Clofarabine Triphosphate in Patients with Acute Leukemias

Clinical cancer research, 2003-12, Vol.9 (17), p.6335-6342

2003

Volltextzugriff (PDF)

Phase I Clinical and Pharmacology Study of Clofarabine in Patients With Solid and Hematologic Cancers

Journal of clinical oncology, 2003-03, Vol.21 (6), p.1167-1173

2003

Volltextzugriff (PDF)

Chronic myelogenous leukemia in nonlymphoid blastic phase: Analysis of the results of first salvage therapy with three different treatment approaches for 162 patients

Cancer, 1999-12, Vol.86 (12), p.2632-2641

1999

Volltextzugriff (PDF)

Treatment of Philadelphia Chromosome-Positive Early Chronic Phase Chronic Myelogenous Leukemia With Daily Doses of Interferon Alpha and Low-Dose Cytarabine

Journal of clinical oncology, 1999-01, Vol.17 (1), p.284-292

1999

Volltextzugriff (PDF)

Imatinib mesylate for Philadelphia chromosome-positive, chronic-phase myeloid leukemia after failure of interferon-α: Follow-up results

Clinical cancer research, 2002-07, Vol.8 (7), p.2177-2187

2002

Volltextzugriff (PDF)

Imatinib mesylate therapy improves survival in patients with newly diagnosed Philadelphia chromosome-positive chronic myelogenous leukemia in the chronic phase: Comparison with historic data

Cancer, 2003-12, Vol.98 (12), p.2636-2642

2003

Volltextzugriff (PDF)

Treatment of Philadelphia Chromosome-positive, Accelerated-phase Chronic Myelogenous Leukemia with Imatinib Mesylate

Clinical cancer research, 2002-07, Vol.8 (7), p.2167-2176

2002

Volltextzugriff (PDF)

Characteristics and outcome of patients with Philadelphia chromosome negative, bcr/abl negative chronic myelogenous leukemia

Cancer, 2002-10, Vol.95 (8), p.1673-1684

2002

Volltextzugriff (PDF)

Survival Advantage with Imatinib Mesylate Therapy in Chronic-Phase Chronic Myelogenous Leukemia (CML-CP) after IFN-α Failure and in Late CML-CP, Comparison with Historical Controls

Clinical cancer research, 2004-01, Vol.10 (1), p.68-75

2004

Volltextzugriff (PDF)

Opioid receptor stimulation suppresses the adrenal medulla hypoxic response in sheep by actions on Ca2+ and K+ channels

The Journal of physiology, 2004-03, Vol.555 (2), p.489-502

2004

Volltextzugriff (PDF)

Opioid receptor stimulation suppresses the adrenal medulla hypoxic response in sheep by actions on Ca(2+) and K(+) channels

The Journal of physiology, 2004-03, Vol.555 (Pt 2), p.489-502

2004

Volltextzugriff (PDF)

Simultaneous homoharringtonine and interferon‐α in the treatment of patients with chronic‐phase chronic myelogenous leukemia

Cancer, 2002-04, Vol.94 (7), p.2024-2032

2002

Volltextzugriff (PDF)

Sudden onset of the blastic phase of chronic myelogenous leukemia: Patterns and implications

Cancer, 2003-07, Vol.98 (1), p.81-85

2003

Volltextzugriff (PDF)

Homoharringtonine Therapy Induces Responses in Patients With Chronic Myelogenous Leukemia in Late Chronic Phase

Blood, 1995-11, Vol.86 (9), p.3322-3326

1995

Volltextzugriff (PDF)

Phase I Study of Topotecan, A New Topoisomerase I Inhibitor, in Patients With Refractory or Relapsed Acute Leukemia

Blood, 1993-03, Vol.81 (5), p.1146-1151

1993

Volltextzugriff (PDF)

Fludarabine and Arabinosylcytosine Therapy of Refractory and Relapsed Acute Myelogenous Leukemia

Leukemia & lymphoma, 1993, Vol.9 (4-5), p.343-350

1993

Volltextzugriff (PDF)

Suppression of cytogenetic clonal evolution with interferon alfa therapy in patients with Philadelphia chromosome-positive chronic myelogenous leukemia

Journal of clinical oncology, 1998-10, Vol.16 (10), p.3279-3285

1998

Volltextzugriff (PDF)

Treatment of chronic myelogenous leukemia in accelerated and blastic phases with daunorubicin, high-dose cytarabine, and granulocyte-macrophage colony-stimulating factor

Journal of clinical oncology, 1992-03, Vol.10 (3), p.398-405

1992

Volltextzugriff (PDF)

1 – 25 von 28

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(28)
Mit Volltextzugriff
(28)

Publikationsform

Artikel
(28)

Sprache

Englisch
(28)

Erscheinungsjahr

n.n

Thema

Humans
(24)
Life Sciences & Biomedicine
(24)
Science & Technology
(24)
Biological And Medical Sciences
(21)
Medical Sciences
(21)
Oncology
(19)
Middle Aged
(18)
Adult
(17)
Antineoplastic Agents
(17)
Female
(17)
Pharmacology. Drug Treatments
(17)
Male
(16)
Leukemia, Myelogenous, Chronic, Bcr-Abl Positive - Drug Therapy
(13)
Aged
(12)
Prognosis
(11)
Chemotherapy
(10)
Treatment Outcome
(9)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(8)
Drug Administration Schedule
(8)
Survival Rate
(8)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The Proceedings of the Initial Meeting of the Society of Hematologic Oncology 2013

Retrospect of Hematological Malignancies 2012

The Combination of Alemtuzumab [Continuous Intravenous Infusion (civ) Followed by Subcutaneous Injection (sc)] Plus Rituximab Has Activity in Patients (pts) with Relapsed Chronic Lymphocytic Leukemia (CLL)

Bronchial thermoplasty: Long-term safety and effectiveness in patients with severe persistent asthma

Pregnancy Among Patients With Chronic Myeloid Leukemia Treated With Imatinib

Complete cytogenetic and molecular responses to interferon‐α‐based therapy for chronic myelogenous leukemia are associated with excellent long‐term prognosis

Results of decitabine (5‐aza‐2′deoxycytidine) therapy in 130 patients with chronic myelogenous leukemia

Pharmacokinetics and Pharmacodynamics of Plasma Clofarabine and Cellular Clofarabine Triphosphate in Patients with Acute Leukemias

Phase I Clinical and Pharmacology Study of Clofarabine in Patients With Solid and Hematologic Cancers

Chronic myelogenous leukemia in nonlymphoid blastic phase: Analysis of the results of first salvage therapy with three different treatment approaches for 162 patients

Treatment of Philadelphia Chromosome-Positive Early Chronic Phase Chronic Myelogenous Leukemia With Daily Doses of Interferon Alpha and Low-Dose Cytarabine

Imatinib mesylate for Philadelphia chromosome-positive, chronic-phase myeloid leukemia after failure of interferon-α: Follow-up results

Imatinib mesylate therapy improves survival in patients with newly diagnosed Philadelphia chromosome-positive chronic myelogenous leukemia in the chronic phase: Comparison with historic data

Treatment of Philadelphia Chromosome-positive, Accelerated-phase Chronic Myelogenous Leukemia with Imatinib Mesylate

Characteristics and outcome of patients with Philadelphia chromosome negative, bcr/abl negative chronic myelogenous leukemia

Survival Advantage with Imatinib Mesylate Therapy in Chronic-Phase Chronic Myelogenous Leukemia (CML-CP) after IFN-α Failure and in Late CML-CP, Comparison with Historical Controls

Opioid receptor stimulation suppresses the adrenal medulla hypoxic response in sheep by actions on Ca2+ and K+ channels

Opioid receptor stimulation suppresses the adrenal medulla hypoxic response in sheep by actions on Ca(2+) and K(+) channels

Simultaneous homoharringtonine and interferon‐α in the treatment of patients with chronic‐phase chronic myelogenous leukemia

Sudden onset of the blastic phase of chronic myelogenous leukemia: Patterns and implications

Homoharringtonine Therapy Induces Responses in Patients With Chronic Myelogenous Leukemia in Late Chronic Phase

Phase I Study of Topotecan, A New Topoisomerase I Inhibitor, in Patients With Refractory or Relapsed Acute Leukemia

Fludarabine and Arabinosylcytosine Therapy of Refractory and Relapsed Acute Myelogenous Leukemia

Suppression of cytogenetic clonal evolution with interferon alfa therapy in patients with Philadelphia chromosome-positive chronic myelogenous leukemia

Treatment of chronic myelogenous leukemia in accelerated and blastic phases with daunorubicin, high-dose cytarabine, and granulocyte-macrophage colony-stimulating factor

Suchergebnisse filtern